SCHEMBL5209503

SCHEMBL5209503

CCN(C)Cc1c(C)nn(-c2ccc(-c3ccc(F)cc3)cc2)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
SMO Q99835 1/20 0.42
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
NR3C1 P04150 1/20 0.38
PTGS2 P35354 3/20 0.37
PTGS1 P23219 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2003468 0.84 AR (0.48) SMOCYP1A2SMN1; SMN2ARNPC1
SCHEMBL5206995 0.77 SMO (0.58) ALDH1A1NPSR1SMOL3MBTL1MEN1
SCHEMBL1999864 0.72 CYP2C9 (0.50) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL31500050 0.72 SMN1; SMN2 (0.56) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL11247967 0.71 CYP2C9 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19PTGS2
SCHEMBL2001301 0.69 P2RX7 (0.42) ALDH1A1NPSR1SMOCYP1A2CYP2C9
SCHEMBL1997120 0.69 ALDH1A1 (0.53) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL1195159 0.65 CYP2C9 (0.62) ALDH1A1CYP1A2CYP2C9CYP2C19PDE4D
SCHEMBL1999559 0.65 SMO (0.65) SMOCYP1A2MAPTARMEN1
SCHEMBL1999485 0.65 NR3C2 (0.40) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611094-B1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-20 EP disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A ALDH1A1 1220/4885NPSR1 21/4885SMO 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.